Nov 17, 2019
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
Sep 02, 2019
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
Mar 15, 2019
Valisure Expands Capabilities To Test Medications For Cancer Causing Contaminants Implicated In Recent Recalls
Mar 12, 2019
FDA approves a new generic valsartan
Mar 09, 2019
Information Update - Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Mar 01, 2019
FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
Jan 11, 2019
Bernstein Liebhard LLP Evaluating Potential Valsartan Lawsuits for Cancer and Liver Injuries Allegedly Caused by Contaminated Heart and Blood Pressure Medications
Nov 28, 2018
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
Nov 20, 2018
FDAnews Announces -- Chinese Medicine: The Dangers of Deployment Webinar, Nov. 29, 2018
Nov 11, 2018
New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients
Sep 13, 2018
FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm's already recalled products
Aug 30, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA's ongoing investigation into valsartan impurities and recalls and an update on FDA's current findings
Aug 20, 2018
/R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
Jul 13, 2018
FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity
Jul 10, 2018
Investigation Report on the Chinese Valsartan (Diovan) Market 2018-2022: Sales, Market Shares, Prices and Prospects
Jul 10, 2018
Update - Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Jul 09, 2018
Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Jun 13, 2018
Nutriband Inc. Signs LOI to Acquire Carmel Biosciences
May 28, 2018
Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®
Sep 19, 2017
New analysis shows Entresto improved physical and social activity in patients with HFrEF